ArticleFrontiers in immunology2022

Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.

Xiaoshuo Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.